Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.

NCT04649632 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT04649632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04649632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
April 29, 2020
Completion date
September 18, 2020
Enrollment
451 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post stroke spasticity